logo
  

Holcim Agrees To Buy Germany's Heinrich Teufel For Undisclosed Financial Terms

Swiss building material company Holcim AG (HCMLY.PK,HCMLF.PK), formerly known as LafargeHolcim, Tuesday said it has reached an agreement to acquire Heinrich Teufel GmbH & Co.KG, a German aggregates and ready-mix concrete company. The company did not reveal the financial terms of the transaction.

The deal is subject to approval by the antitrust authorities.

Following the acquisition, Heinrich Teufel will continue to operate under its present name for the time being.

Heinrich Teufel operates a limestone quarry with an asphalt mixing plant and a ready-mix concrete plant, as well as a recycling park and a demolition company. The company employs around 160 people, most of them at the plant in Strassberg.

Miljan Gutovic, Region Head EMEA, said, "The acquisition of Heinrich Teufel will strengthen our footprint in southern Germany in aggregates and ready-mixed concrete. We were especially impressed by their shared commitment to advancing the circular economy."

In Switzerland, Holcim shares were trading at 54.54 Swiss francs, down 0.6 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT